| York General Hearthstone | |
| 2600 North Lincoln Avenue, York, Nebraska 68467 | |
| (402) 362-4333 | |
| Name | York General Hearthstone |
|---|---|
| Location | 2600 North Lincoln Avenue, York, Nebraska |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 127 |
| Occupancy Rate | 66.69% |
| Medicare ID (CCN) | 285131 |
| Legal Business Name | York General Hospital |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1023194669 |
| Organization Name | YORK GENERAL HOSPITAL |
| Doing Business As | YORK GENERAL HEARTHSTONE |
| Address | 2600 N Lincoln Ave, York, NE 68467 |
| Phone Number | 402-362-4333 |
News Archive
In his first big speech as President Barack Obama's top Medicare official Donald Berwick Monday called on insurers to join in a "full partnership" with his agency to achieve a health system with lower costs that doesn't withhold care from anyone or risk harming patients, The Associated Press/Washington Post report. The remarks were delivered to a conference hosted by America's Health Insurance Plans. "The choice of the insurance lobby for his speech was unusual since the administration continues to trade verbal potshots with the industry" (Alonso-Zaldivar, 9/13).
Cancer Research UK's Centre for Drug Development, in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.
Quintiles today issued the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle. "Lifecycle Modeling and Simulation: Current Practice and Future Impact on Healthcare Innovation and Delivery" discusses the potential of modeling and simulation to advance healthcare delivery through applications in drug development.
Flexpoint Sensor Systems, Inc. today announced that it has received follow-up orders from long standing clients Bridgepoint and Intertek. The orders will be completed and shipped before the close of the year.
A new machine learning platform can identify patients with colorectal cancer and helps predict their disease severity and survival, according to a study involving samples from thousands of subjects.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In his first big speech as President Barack Obama's top Medicare official Donald Berwick Monday called on insurers to join in a "full partnership" with his agency to achieve a health system with lower costs that doesn't withhold care from anyone or risk harming patients, The Associated Press/Washington Post report. The remarks were delivered to a conference hosted by America's Health Insurance Plans. "The choice of the insurance lobby for his speech was unusual since the administration continues to trade verbal potshots with the industry" (Alonso-Zaldivar, 9/13).
Cancer Research UK's Centre for Drug Development, in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.
Quintiles today issued the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle. "Lifecycle Modeling and Simulation: Current Practice and Future Impact on Healthcare Innovation and Delivery" discusses the potential of modeling and simulation to advance healthcare delivery through applications in drug development.
Flexpoint Sensor Systems, Inc. today announced that it has received follow-up orders from long standing clients Bridgepoint and Intertek. The orders will be completed and shipped before the close of the year.
A new machine learning platform can identify patients with colorectal cancer and helps predict their disease severity and survival, according to a study involving samples from thousands of subjects.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.16 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.3 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.92 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.51 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.57 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.38 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.53 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.55 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 32.61 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.85 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.18 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.98 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 91.15 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
In his first big speech as President Barack Obama's top Medicare official Donald Berwick Monday called on insurers to join in a "full partnership" with his agency to achieve a health system with lower costs that doesn't withhold care from anyone or risk harming patients, The Associated Press/Washington Post report. The remarks were delivered to a conference hosted by America's Health Insurance Plans. "The choice of the insurance lobby for his speech was unusual since the administration continues to trade verbal potshots with the industry" (Alonso-Zaldivar, 9/13).
Cancer Research UK's Centre for Drug Development, in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.
Quintiles today issued the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle. "Lifecycle Modeling and Simulation: Current Practice and Future Impact on Healthcare Innovation and Delivery" discusses the potential of modeling and simulation to advance healthcare delivery through applications in drug development.
Flexpoint Sensor Systems, Inc. today announced that it has received follow-up orders from long standing clients Bridgepoint and Intertek. The orders will be completed and shipped before the close of the year.
A new machine learning platform can identify patients with colorectal cancer and helps predict their disease severity and survival, according to a study involving samples from thousands of subjects.
› Verified 9 days ago
York General Hearthstone Location: 2600 North Lincoln Avenue, York, Nebraska 68467 Phone: (402) 362-4333 |